Figure 5 from Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses
Le résumé fourni par la source
LME-sEVs decrease CD8+ T-cell functions. A and B, Percentages (A) and numbers (B) of CD62L−KLRG1+ CD8+ T cells after 48 hours of treatment with LME- and HCME-sEVs assessed by FC. C, Expression of ICP on CD62L−KLRG1+ CD8+ T cells from B. HSNE clustering depicting treatments, cluster identity, and marker expression. D, Hierarchical clustering based on ICP expression. E, Percentages of PD1+TIM3+ICOS+ CD8+ T cells from cluster C1 (top) and of PD1+LAG3+TIM3+TIGIT+ICOS+ CD8+ T cells from cluster C8 (bottom). F–I, CD8+ T cells were isolated from C57BL/6 and CLL cells from TCL1 mice. F, Percentage of T cell–mediated killing of TCL1 cells (cytotoxic assay) in the presence of HCME-sEVs or LME-sEVs (N = 6). G, Quantification of CD8+ T-cell:TCL1 cell conjugates upon treatment with LME- or HCME-sEVs (N = 3–4) and representative images (scale bar, 10 μm). H, Quantification of immune synapse formation (F-actin area in μm2, HCME-, n = 31 and LME-sEVs, n = 39, dashed line representing median) and representative medial optical sections (scale bar, 5 μm) with arrows indicating the synapse. I, Mean Fluorescence intensity (MFI) of GzmB at the synapse between CD8+ T and CLL cells (HCME-, n = 31 and LME-sEVs, n = 51) and representative 3D volume-rendered images. J, miRNA levels quantified by RT-qPCR in CD8+ T cells treated with HCME- or LME-sEVs for 24 hours. K, Protein levels of miRNA targets determined by FC in CD8+ T cells treated for 48 hours with HCME-sEVs or LME-sEVs transfected with scramble or antagomiRs (miR-150, -155, and -378a). Preincubation of LME-sEVs with heparin was used as an inhibitor of sEV internalization. L, ICP levels determined by FC in CD8+ T cells treated for 48 hours with HCME-sEVs or LME-sEVs preincubated with blocking Abs (PD-L1, GAL9, VISTA, and MHC-II) or corresponding isotypes. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (unpaired Student t test). Data are mean.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.
- Titre Crossref
- Figure 5 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
- Date Crossref
- 24/11/2025
- Éditeur
- American Association for Cancer Research (AACR)
- Type
- posted-content
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.